RxDoctor Payments DataLook up a doctor →

Julian Molina, MD

Medical Oncology · Rochester, MNNPI 1013989037

Payments from drug & device makers

$989,571in general payments, 2019–2025

Across 60 payments — averaging $16,493 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$837K
  • Genentech, Inc.$123K
  • Takeda Pharmaceuticals U.S.A., Inc.$17K
  • Spectrum Pharmaceuticals Inc.$12K
  • Amgen$25

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$989,571 in reported general payments places this provider in the 70th percentile of 133 medical oncology providers in Minnesota.

See all medical oncology providers in Minnesota

Medicare billing

Part B allowed, 2024
$1,750,171
Medicare patients
391
Services billed
63,056

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →